Stockreport

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF company with two programs in ongoing clinical trials and a strong emerging pipeline, today reported financial results for the second quarter of 2024 and provided an upda [Read more]